2025
December
IL-9-powered CAR-T for improved solid tumor responses
December 3, 2025
Overcoming immunosuppression in the tumor microenvironment (TME) is a major challenge in CAR T cell research to improve therapeutic efficacy towards solid tumors. To address some of the CAR-T functionality challenges, Castelli et al. engineered CAR T cells with an authentic IL-9 receptor (IL-9R) to enable IL-9 responsiveness. These CAR-T were assessed in...
